Yahoo Web Search

Search results

  1. Jennifer Anne Doudna ForMemRS (/ ˈ d aʊ d n ə /; born February 19, 1964) is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences.

  2. May 9, 2024 · Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.

    • Kara Rogers
  3. Jennifer Doudna is a Nobel Laureate in Chemistry and a pioneer of CRISPR-Cas9 genome editing technology. She leads a research group at UC Berkeley and the Innovative Genomics Institute, and is involved in various projects to apply CRISPR to medicine, microbiomes, and climate change.

    • Jennifer Doudna1
    • Jennifer Doudna2
    • Jennifer Doudna3
    • Jennifer Doudna4
  4. The Nobel Prize in Chemistry 2020. Born: 19 February 1964, Washington, D.C., USA. Affiliation at the time of the award: University of California, Berkeley, CA, USA. Prize motivation: “for the development of a method for genome editing”. Prize share: 1/2.

  5. People also ask

  6. The outbreak motivated me to pivot to RNA interference, a phenomenon that plays a fundamental role in a number of important functions, including how the human immune system fights off viral infections. RNA interference silences unwanted genetic messages, thereby blocking the production of the proteins they code for.

  7. Oct 7, 2020 · Doudna and Emmanuelle Charpentier share the prize for the co-development of CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine. Doudna is the first woman on the UC Berkeley faculty to win the Nobel Prize and a leader in RNA research and innovation.

  8. Jun 17, 2021 · Jennifer A. Doudna is a Howard Hughes Medical Institute Investigator and a Professor of Molecular Therapeutics at UC Berkeley. She studies RNA-mediated control of the genome, including CRISPR-Cas systems, and develops novel genome editing tools.

  1. People also search for